This inventor holds 2 USPTO granted patents. Top assignee: Imperial Chemical Industries Limited. Active years: 1977.
Company Filing History:
Years Active: 1977
Title: The Innovations of Stephen Collyer Smith
Introduction
Stephen Collyer Smith is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of chemistry, particularly in the development of indole derivatives. With a total of 2 patents to his name, his work has implications in pharmaceutical applications.
Latest Patents
Smith's latest patents include a process for the manufacture of indole derivatives. This process involves the manufacture of 1-(quinazolin-4-yl)indol-3-ylacetic acids and salts thereof by reacting a phenylhydrazone derivative with a quinazoline derivative, such as a halogenoquinazoline. The resulting intermediate product undergoes ring-closing, leading to the creation of compounds with potential therapeutic benefits. An illustrative product of this process is 1-(7-chloroquinazolin-4-yl)-5-methoxy-2-methylindol-3-ylacetic acid. Additionally, he has developed indole derivatives that provide analgesic and anti-inflammatory effects. These include 1-(Heterocyclic)-indol-3-ylacetic acid derivatives, which have been shown to possess anti-inflammatory, analgesic, and antipyretic activity.
Career Highlights
Stephen Collyer Smith is associated with Imperial Chemical Industries Limited, where he has contributed to various innovative projects. His work has been instrumental in advancing the understanding and application of indole derivatives in medicinal chemistry.
Collaborations
Throughout his career, Smith has collaborated with notable colleagues, including George Richard Birchall and Walter Hepworth. These collaborations have further enriched his research and development efforts.
Conclusion
Stephen Collyer Smith's contributions to the field of chemistry, particularly through his patents on indole derivatives, highlight his innovative spirit and dedication to advancing pharmaceutical science. His work continues to influence the development of new therapeutic compounds.
